DR. CHARLES F. MESS JR., M.D.

Plain English
This study looked at two potential markers, S100A8/A9 and neutrophils, in patients with advanced melanoma undergoing treatment with immune-checkpoint inhibitors. They found that higher levels of S100A8/A9 and neutrophils were linked to worse outcomes, with patients showing elevated levels at the start and during treatment experiencing poorer progression-free survival and overall survival. These findings are important because they could help doctors predict which patients are less likely to respond to treatment and tailor therapies accordingly. Who this helps: This helps melanoma patients and their doctors by providing better tools to assess treatment responses.

Plain English
This study looked at how well two types of lasers—a carbon dioxide (CO2) laser and a 1927 nm thulium (Tm) laser—help deliver hyaluronic acid injections, which improve skin hydration and quality. Researchers found that hyaluronic acid penetrated the skin effectively with both lasers; however, the CO2 laser caused more inflammation that lasted for 30 days, while the Tm laser allowed the skin to return to its normal state by that time. The results show that while the CO2 laser may deliver treatment more effectively, the Tm laser offers a gentler option with less downtime after treatment. Who this helps: Patients seeking skin treatment options with minimal recovery time.

Plain English
This study looked at how different types of long-lasting itching, particularly in conditions like atopic dermatitis and non-lesional skin with atopic tendencies, affect patients' experiences and treatment goals. It involved 1,086 adults, finding that while those with atopic dermatitis experienced more severe symptoms and a greater impact on their quality of life, 92.6% of patients shared similar treatment goals, mainly wanting relief from itching and effective treatment options. Understanding these needs helps healthcare providers better address the concerns of patients dealing with chronic itching. Who this helps: This benefits patients with chronic itching conditions and their doctors.

Plain English
This study examined how red blood cells (RBCs) from patients with breast and lung cancer affect the behavior of tumor cells in the bloodstream. The researchers found that tumor cells interacted differently with RBCs from cancer patients compared to healthy donors, leading to increased tumor cell attachment and invasiveness. Specifically, RBCs from patients with metastatic breast cancer were linked to more aggressive tumor behavior and worse outcomes, which can be identified by higher red blood cell distribution width (RDW) measurements. Who this helps: This information benefits cancer patients by highlighting potential new treatment targets to slow down tumor progression.

Plain English
This study looked at how patients with chronic itching (called chronic pruritus) from different conditions, like liver disease, kidney disease, and eczema, experience psychological stress. It found that patients with liver or kidney issues reported significantly higher levels of psychological distress compared to those with eczema. Specifically, those with liver and kidney diseases felt much more anxious and depressed, while eczema patients reported feeling their quality of life was more affected. These findings stress the importance of treating not just the physical symptoms but also the mental health aspects of chronic itching for all patient groups. Who this helps: This helps patients with chronic pruritus and their doctors by emphasizing the need for comprehensive treatment approaches.

Plain English
This study looked at how tattoo particles are removed from the skin after patients receive a picosecond laser treatment for tattoo removal. Researchers followed nine patients with eleven tattoos and found that six weeks after treatment, tattoo particles were still present in the skin but had moved closer to the skin's surface. By 12 weeks, while there were fewer particles, they were still detected, suggesting that the removal process takes several months. This matters because it implies that allowing more time between laser treatments might improve results in tattoo removal. Who this helps: Patients looking to remove tattoos safely and effectively.

Plain English
This study aimed to create and test a new tool called the Pruritus-Associated Stress Scale (PASS) to measure stress related to itching in patients with chronic skin conditions. Out of 55 patients, 94.5% felt stressed about their itching in the last two weeks, and the tool showed strong reliability. This matters because it helps accurately identify and understand the stress that comes from itching, which can improve treatment for patients with itchy skin conditions. Who this helps: Patients with chronic itching conditions like atopic dermatitis and chronic prurigo.

Plain English
This study looked at how well a drug called secukinumab helps reduce itching and improve skin nerve structure in patients with psoriasis. It found that after treatment with secukinumab, patients reported a significant decrease in itching intensity, measuring 12.3 on a scale compared to 29.9 after stopping the drug. This is important because it shows that secukinumab not only improves skin conditions but also helps alleviate one of the most bothersome symptoms, itching. Who this helps: This research benefits patients with psoriasis who experience significant itching and discomfort.

Plain English
This study looked at the levels of von Willebrand factor (a clotting protein) and other blood markers in 83 melanoma patients being treated with immune checkpoint inhibitors (ICIs). It found that patients with lower levels of von Willebrand factor at the start of treatment were more likely to respond successfully to the therapy (29.4 vs. 32.9 µg/mL, p=0.048) and had better overall survival, linking it to longer-lasting benefits from the treatment. Understanding these blood markers could help doctors better predict how well patients will respond to ICI treatments for melanoma. Who this helps: Patients with metastatic melanoma receiving immunotherapy.

Plain English
This study looked at how effectively hyaluronic acid (HA), a substance used to hydrate and heal skin, can be delivered into the skin after a laser treatment called ablative fractional laser (AFL). Researchers found that after the AFL treatment, HA was present in all layers of the skin, while in untreated skin, it was only found in the top layer at lower amounts. This method not only improves hydration and helps skin heal but also shows promise for personalizing treatments for better results. Who this helps: This helps patients seeking skin rejuvenation and effective healing treatments.

Plain English
This research studied a specific mutation in von Willebrand factor (VWF), called p.Pro2555Arg, which is important for blood clotting. The findings revealed that this mutation increases the size of blood platelet clusters, making them more likely to cause clots, which can lead to health issues. For example, the mutation alters the structure of VWF in a way that it enhances the ability for platelets to stick together, potentially increasing clot formation. Who this helps: This information is beneficial for doctors and researchers addressing blood clotting disorders and thromboembolic events.

Plain English
This study focuses on understanding why some people continue to experience chronic itching, known as chronic pruritus, even after the initial cause has been treated. Researchers are looking at 120 patients in Germany with different types of skin conditions and will assess various biological and psychological factors that might contribute to the ongoing itching. They expect to find connections between chronic itching and factors like fatigue and pain, which could affect about 20% of the general population experiencing this symptom. Who this helps: This benefits patients suffering from chronic itching and their doctors by providing insights into why symptoms persist and how to manage them.

Plain English
This study looked at how a new imaging technique can help doctors see and understand changes in the skin caused by tattoos. Researchers found that they could visualize tattoo particles in the skin and assess inflammation and other changes over time using a method called multiphoton tomography combined with fluorescence lifetime imaging. This matters because it offers a non-invasive way to diagnose and treat allergic reactions or infections related to tattoos, improving care for patients with tattoos. Who this helps: Patients with tattoos experiencing skin issues.

Plain English
This research studied how certain immune cells, called eosinophils, affect the treatment response of melanoma patients receiving a type of therapy known as immune checkpoint inhibition. The researchers found that patients with higher levels of activated eosinophils and T-cells in their tumors experienced longer periods without cancer progression; specifically, those with high eosinophil counts saw improved results. This is important because it suggests eosinophils could be used as a marker to predict which patients might benefit more from this treatment. Who this helps: This helps melanoma patients and their doctors make more informed treatment decisions.

Plain English
This study looked at how neutrophil extracellular traps (NETs), which are DNA fibers released during inflammation, affect blood flow and clotting. The researchers found that these DNA fibers slow down blood flow and can block blood vessels, even without involvement from the usual blood clotting processes. Additionally, this blockage triggers activation of a part of the immune system called the complement system, which reinforces the formation of NETs. Who this helps: This benefits patients with conditions like COVID-19, cancer, and antiphospholipid syndrome, where inflammation and blood clotting are problematic.

Plain English
This study examined the role of a substance called von Willebrand factor (VWF) in the growth of melanoma tumors that spread to the brain. Researchers found that patients with brain metastases had higher levels of VWF in their blood, which was linked to increased blood clot formation and tumor growth. In animal models, blocking platelet activation or using blood thinners significantly reduced the spread of melanoma to the brain. Who this helps: This research benefits patients with melanoma and brain metastases by suggesting new treatment options.

Plain English
This study focused on how certain genetic changes in a protein called ADAMTS13, which is important for blood clotting, behave under different conditions. Researchers found that while standard tests indicated low activity of ADAMTS13 in some patients with Upshaw-Schulman syndrome (USS), these protein variants could actually break down about 80-90% of a key blood component (von Willebrand factor) when studied in more realistic flow conditions. This suggests that existing tests may underestimate the activity of this protein in patients, which is crucial for proper diagnosis and treatment of conditions like Thrombotic Thrombocytopenic Purpura. Who this helps: This helps patients with Upshaw-Schulman syndrome and their doctors by improving understanding and assessment of their condition.

Plain English
This study looked at how drugs can better penetrate the skin to treat skin diseases by examining the different barriers in the skin, like the outer layer and hair follicles. It found that understanding these barriers is crucial for developing more effective treatments. The researchers reviewed various methods for measuring how well drugs can pass through these barriers and noted that skin changes in patients with atopic dermatitis can make drug delivery harder. Who this helps: This benefits patients with skin diseases, especially those with atopic dermatitis.

Plain English
This study focused on how different parts of a protein called von Willebrand factor (VWF) affect how platelets stick together and to blood vessel walls. Researchers found that removing the A1-domain of VWF decreased platelet adhesion and aggregation significantly, while removing the A2-domain unexpectedly increased the formation of platelet clusters. This matters because understanding these interactions can help us learn more about how blood clots form and lead to better treatments for clot-related conditions. Who this helps: This helps patients with bleeding disorders and doctors treating clotting issues.

Plain English
This study looked at how stressed red blood cells (erythrocytes) interact with a specific protein called von Willebrand factor (VWF), which can lead to blockages in small blood vessels and organ damage. The researchers found that when red blood cells are under stress, they stick to VWF fibers more strongly, especially in situations like kidney injury. In their experiments, they noticed that this adherence happened more in normal mice compared to those without VWF, and patients with chronic kidney failure showed higher levels of these interactions in their blood. Who this helps: This research benefits patients with conditions that affect blood flow and organ function, particularly those with kidney disease.

Plain English
This study looked at how a special imaging technique can help us understand inflammation in skin conditions like atopic dermatitis. Researchers found that in inflamed skin, mitochondria (the cell's power producers) moved closer to the cell nucleus, which shows a change in how cells are working; specifically, healthy skin had an even mitochondrial distribution, while inflamed skin showed a buildup near the nucleus. This new method can allow for earlier diagnosis and more personalized treatments for patients with skin inflammation. Who this helps: This helps patients with inflammatory skin diseases.

Plain English
This study looked at how different proteins in the body affect itching, particularly a protein called endothelin-1 (ET-1) which can cause itchiness without involving histamine, a common itch trigger. The researchers found that inhibiting an enzyme called ECE-1 increased scratching in mice and that this pathway is also active in humans with chronic itch, as seen in patients with prurigo nodularis. This matters because it identifies a new target for potential treatments for people suffering from severe itching. Who this helps: This helps patients with chronic itch-related conditions.

Plain English
This study looked at rosacea, a long-lasting skin condition that causes inflammation and redness, but whose exact cause is still unknown. Researchers found that there are different types of rosacea, and while genetics may play a role, no specific gene has been pinpointed yet. This matters because understanding the biological processes involved in rosacea can lead to better treatments, especially since it can cause more serious skin changes over time. Who this helps: This helps patients with rosacea and their doctors in managing the condition more effectively.

Plain English
This study looked at the underlying causes of rosacea, a common skin condition that makes the face red and can be painful. Researchers found that people with rosacea had more dilated blood vessels and an increase in certain immune and nerve cells compared to people with healthy skin. These changes may start early in the disease and suggest that targeting nerve and blood vessel interactions could improve treatments for rosacea patients. Who this helps: This helps patients suffering from rosacea, particularly those experiencing discomfort and cosmetic concerns.